Search Results - "van den Hoogen, M.W.F."

Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double‐Blind, Placebo‐Controlled Study of Efficacy and Safety by van den Hoogen, M. W. F., Kamburova, E. G., Baas, M. C., Steenbergen, E. J., Florquin, S., M. Koenen, H. J. P., Joosten, I., Hilbrands, L. B.

“…We evaluated the efficacy and safety of rituximab as induction therapy in renal transplant patients. In a double‐blind, placebo‐controlled study, 280 adult…”
Get full text

Anti-B cell therapy with rituximab as induction therapy in renal transplantation by Joosten, I, Baas, M.C, Kamburova, E.G, van den Hoogen, M.W.F, Koenen, H.J.P.M, Hilbrands, L.B

“…Abstract Traditionally, antirejection therapy in organ transplantation has mainly been directed at T cells. During recent years, the role of B cells in acute…”
Get full text

Safety and feasibility of 2 h of normothermic machine perfusion of donor kidneys in the Eurotransplant Senior Program by Rijkse, E, de Jonge, J, Kimenai, H J A N, Hoogduijn, M J, de Bruin, R W F, van den Hoogen, M W F, IJzermans, J N M, Minnee, R C

“…The 5-year graft survival rate of donor kidneys transplanted in the Eurotransplant Senior Program (ESP) is only 47 per cent. Normothermic machine perfusion…”
Get full text

Care for the organ transplant recipient on the intensive care unit by van den Hoogen, M.W.F., Seghers, L., Manintveld, O.C., Roest, S., Bekkers, J.A., den Hoed, C.M., Minnee, R.C., de Geus, H.R.H., van Thiel, R.J., Hesselink, D.A.

“…All transplant recipients receive tacrolimus, mycophenolate and glucocorticoids and these drugs have many side-effects and drug-drug interactions. Common…”
Get full text

Treatment of Steroid‐Resistant Acute Renal Allograft Rejection With Alemtuzumab by van den Hoogen, M. W. F., Hesselink, D. A., van Son, W. J., Weimar, W., Hilbrands, L. B.

“…Steroid‐resistant renal allograft rejections are commonly treated with rabbit antithymocyte globulin (RATG), but alemtuzumab could be an effective, safe and…”
Get full text

Three‐Year Outcomes of Belatacept Studies; Reason to Be Optimistic? by van den Hoogen, M. W. F., Pipeleers, L.

Get full text